CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.
about
Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date reviewTargeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentOxidative stress and cytokines in the pathogenesis of pancreatic cancerChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR2: a target for pancreatic cancer treatment?Targeting tumor-associated macrophages to combat pancreatic cancerOrchestration of angiogenesis by immune cellsSoluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxificationGlioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.Selected cytokines in patients with pancreatic cancer: a preliminary report.Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled studyTranscription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype.The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.CCL20/CCR6 expression profile in pancreatic cancerThe role of chemoattractant receptors in shaping the tumor microenvironment.Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomasLeptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cellsIdentification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.Blockade of leukocyte haptokinesis and haptotaxis by ketoprofen, diclofenac and SC-560.A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk.The emerging role of CXC chemokines and their receptors in cancer.Cancer associated fibroblasts and tumor growth: focus on multiple myelomaCirculating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapyCXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapyIdentification and validation of genes involved in gastric tumorigenesis.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbCXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissuemiR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study.A Preclinical Evaluation of Antrodia camphorata Alcohol Extracts in the Treatment of Non-Small Cell Lung Cancer Using Non-Invasive Molecular Imaging.Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.Interleukin-8, a promising predictor for prognosis of pancreatic cancer.Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survivalEnhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.
P2860
Q26748692-9461C146-17FB-4578-86A8-D1B7CA6E36E6Q26769963-A6B09DDB-B03E-4378-BE25-FAAD1D20BCC9Q26824025-D370AE65-D0B1-429A-B920-6E8C9BBAAEFDQ26866236-3E7EDE30-8844-4A2C-8E2F-8F4F40334598Q27021588-CE6A5433-EA4D-4A69-9C6A-32F42974B8FAQ28076103-67D3DD46-4A00-4AB8-80C5-A5D5AE07568BQ28389236-539E7D51-B7CC-425B-9850-17557C20C4B2Q28822225-F73F255E-3CF5-4771-B16E-1BC2C1C7964FQ31101680-9C4A8020-AEEC-4CC3-B032-4A08843D8E09Q33642464-82E09281-1A0F-4E38-A16B-C3F2D3789E58Q33645140-EE68A72F-8773-4FEC-B83D-E8B53C76245AQ33742692-21886227-D087-430A-8C58-3D2CBC2E4473Q33767021-90439494-E1D9-47E9-AF6F-03CA89E1218DQ33768073-8EF14E7B-F10C-4CD9-8470-53216E7352CEQ33878671-3663B913-EBEC-45A8-A478-472CBA5F92D6Q33993124-96B036B1-AF39-4E31-83A0-5CDBB6C40DEEQ34009162-C4494EC5-BB05-44D4-8F2F-F1C23B1CEEE6Q34010406-8F8070B4-8C06-4761-A750-FFA476D43830Q34048965-1CD14ABE-79B0-42D3-AF5A-FEDB7ED49575Q34073053-14E15C33-7878-4A9E-A03F-A72FC95159CAQ34141581-0EB8E1E6-446A-4CC9-B6D1-44130F6CBEB3Q34263645-B89DF4A2-C4C5-4F1A-9260-AD71FB54C912Q34309899-F4887787-EE8D-49B2-B476-AF4BE88DAEAFQ34316618-4D83366B-2865-4428-8CDD-BCC48959863DQ34363535-5F6CF438-BBDF-4F76-B44A-704CB85024F4Q34419335-BF633C65-300B-43C3-B906-D9BF17B92C7EQ34537320-16A35938-1088-4F7F-8869-A647FBF30E1AQ34537885-31682C10-31DD-4FDE-A2E5-68D9E4F40C48Q34627786-CDC0804A-7457-4655-940F-F8E11A19C8E8Q34787462-9B26DD25-A6F7-42A6-A543-2082E2D4F7D4Q34806228-7A74680A-BA06-42D3-93EF-5BBE559413D6Q35109520-78D0961E-423F-4D1B-BCAC-1D3EA2DE0C6CQ35161476-8423EF30-D01C-4A54-BC59-4BF80399EAC3Q35549511-060D963F-FE53-4C99-A4AA-F2A3EC906850Q35813247-007E771F-4E5B-4A37-A15F-8489DDC64E71Q35997045-B7B645F9-7866-471B-9FAC-7EBFBA8FC929Q36016645-E61FE2A7-0379-4C00-B4A4-52CE4175EB3FQ36041701-822E83A0-C54F-4600-AA57-51F0B923AC9DQ36084097-45C15AF7-C76B-438F-8AD0-7DE1865BB313Q36122605-B1CE17C8-9022-45CB-BADF-87FC240F75E9
P2860
CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CXCL8/IL-8 and CXCL12/SDF-1alp ...... iogenesis in pancreatic cancer
@nl
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@ast
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en-gb
type
label
CXCL8/IL-8 and CXCL12/SDF-1alp ...... iogenesis in pancreatic cancer
@nl
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@ast
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en-gb
prefLabel
CXCL8/IL-8 and CXCL12/SDF-1alp ...... iogenesis in pancreatic cancer
@nl
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@ast
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en-gb
P2093
P2860
P3181
P356
P1476
CXCL8/IL-8 and CXCL12/SDF-1alp ...... ogenesis in pancreatic cancer.
@en
P2093
Akira Yasuda
Hiroki Takahashi
Hiromitsu Takeyama
Hirozumi Sawai
Hitoshi Funahashi
Nobuo Ochi
Sushovan Guha
Yoichi Matsuo
Zhimin Tong
P2860
P304
P3181
P356
10.1002/IJC.24040
P407
P577
2009-02-01T00:00:00Z